Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

The psychedelic psilocybin is being investigated for the treatment of depression and anxiety. Unclear is whether antidepressant treatments interact with psilocybin. The present study used a double‐blind, placebo‐controlled, crossover design with two experimental test sessions to investigate the resp...

Celý popis

Podrobná bibliografia

Vydané v:	Clinical pharmacology and therapeutics Ročník 111; číslo 4; s. 886 - 895
Hlavní autori:	Becker, Anna M., Holze, Friederike, Grandinetti, Tanja, Klaiber, Aaron, Toedtli, Vanja E., Kolaczynska, Karolina E., Duthaler, Urs, Varghese, Nimmy, Eckert, Anne, Grünblatt, Edna, Liechti, Matthias E.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.04.2022
Predmet:	Antidepressive Agents - adverse effects Brain-Derived Neurotrophic Factor - genetics Citalopram - adverse effects Cross-Over Studies Double-Blind Method Escitalopram Healthy Volunteers Humans Psilocybin - adverse effects
ISSN:	0009-9236, 1532-6535, 1532-6535
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!